Cellular therapies supplement: The role of granulocyte macrophage colony-stimulating factor and dendritic cells in regulatory T-cell homeostasis and expansion

Transfusion

Volumn 51, Issue SUPPL. 4, 2011, Pages

  Zou, Tao ^a   Satake, Atsushi ^a   Ojha, Priti ^a   Kambayashi, Taku ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 2; INTERLEUKIN 3; INTERLEUKIN 5; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ARTICLE; CELL EXPANSION; CELL INTERACTION; CELL THERAPY; CYTOKINE PRODUCTION; DENDRITIC CELL; HOMEOSTASIS; HUMAN; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; NONHUMAN; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE;

ANIMALS; AUTOIMMUNITY; CELL COMMUNICATION; CELL DIVISION; CELLS, CULTURED; COCULTURE TECHNIQUES; CYTOKINES; DENDRITIC CELLS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HISTOCOMPATIBILITY; HOMEOSTASIS; HUMANS; IMMUNOTHERAPY, ADOPTIVE; MAST CELLS; T-LYMPHOCYTES, REGULATORY; TOLL-LIKE RECEPTORS;

EID: 81055144328     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2011.03379.x     Document Type: Article

References (59)

1. Kappler JW, Roehm N, Marrack P,. T cell tolerance by clonal elimination in the thymus. Cell 1987; 49: 273-80.
2. Kisielow P, Bluthmann H, Staerz UD, Steinmetz M, von Boehmer H,. Tolerance in T-cell-receptor transgenic mice involves deletion of nonmature CD4+8+ thymocytes. Nature 1988; 333: 742-6.
3. Liston A, Rudensky AY,. Thymic development and peripheral homeostasis of regulatory T cells. Curr Opin Immunol 2007; 19: 176-85. (Pubitemid 46356966)
4. Fontenot JD, Gavin MA, Rudensky AY,. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 2003; 4: 330-6. (Pubitemid 36432314)
5. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M,. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995; 155: 1151-64.
6. Brunkow ME, Jeffery EW, Hjerrild KA, Paeper B, Clark LB, Yasayko SA, Wilkinson JE, Galas D, Ziegler SF, Ramsdell F,. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat Genet 2001; 27: 68-73. (Pubitemid 32044521)
7. Chatila TA, Blaeser F, Ho N, Lederman HM, Voulgaropoulos C, Helms C, Bowcock AM,. JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome. J Clin Invest 2000; 106: R75-81. (Pubitemid 32038594)
8. Bennett CL, Christie J, Ramsdell F, Brunkow ME, Ferguson PJ, Whitesell L, Kelly TE, Saulsbury FT, Chance PF, Ochs HD,. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 2001; 27: 20-1. (Pubitemid 32044513)
9. Hori S, Nomura T, Sakaguchi S,. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003; 299: 1057-61. (Pubitemid 36222930)
10. Wan YY, Flavell RA,. Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression. Nature 2007; 445: 766-70. (Pubitemid 46279706)
11. Khattri R, Cox T, Yasayko SA, Ramsdell F,. An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat Immunol 2003; 4: 337-42. (Pubitemid 36432315)
12. Williams LM, Rudensky AY,. Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3. Nat Immunol 2007; 8: 277-84. (Pubitemid 46745377)
13. Burchill MA, Yang J, Vang KB, Farrar MA,. Interleukin-2 receptor signaling in regulatory T cell development and homeostasis. Immunol Lett 2007; 114: 1-8.
14. Malaviya R, Ikeda T, Ross E, Abraham SN,. Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-alpha. Nature 1996; 381: 77-80. (Pubitemid 26130006)
15. Echtenacher B, Mannel DN, Hultner L,. Critical protective role of mast cells in a model of acute septic peritonitis. Nature 1996; 381: 75-7. (Pubitemid 26130005)
16. Maurer M, Lopez Kostka S, Siebenhaar F, Moelle K, Metz M, Knop J, von Stebut E,. Skin mast cells control T cell-dependent host defense in Leishmania major infections. FASEB J 2006; 20: 2460-7. (Pubitemid 44953818)
17. Li E, Zhou P, Petrin Z, Singer SM,. Mast cell-dependent control of Giardia lamblia infections in mice. Infect Immun 2004; 72: 6642-9. (Pubitemid 39425447)
18. Abe T, Nawa Y,. Reconstitution of mucosal mast cells in W/WV mice by adoptive transfer of bone marrow-derived cultured mast cells and its effects on the protective capacity to Strongyloides ratti-infection. Parasite Immunol 1987; 9: 31-8. (Pubitemid 17026567)
19. Kamiya M, Oku Y, Itayama H, Ohbayashi M,. Prolonged expulsion of adult Trichinella spiralis and eosinophil infiltration in mast cell-deficient W/Wv mice. J Helminthol 1985; 59: 233-9. (Pubitemid 15232443)
20. Biedermann T, Kneilling M, Mailhammer R, Maier K, Sander CA, Kollias G, Kunkel SL, Hültner L, Röcken M,. Mast cells control neutrophil recruitment during T cell-mediated delayed-type hypersensitivity reactions through tumor necrosis factor and macrophage inflammatory protein 2. J Exp Med 2000; 192: 1441-52.
21. Askenase PW, Van Loveren H, Kraeuter-Kops S, Ron Y, Meade R, Theoharides TC, Nordlund JJ, Scovern H, Gerhson MD, Ptak W,. Defective elicitation of delayed-type hypersensitivity in W/Wv and SI/SId mast cell-deficient mice. J Immunol 1983; 131: 2687-94. (Pubitemid 14208815)
22. Kobayashi T, Miura T, Haba T, Sato M, Serizawa I, Nagai H, Ishizaka K,. An essential role of mast cells in the development of airway hyperresponsiveness in a murine asthma model. J Immunol 2000; 164: 3855-61. (Pubitemid 30169844)
23. Williams CM, Galli SJ,. Mast cells can amplify airway reactivity and features of chronic inflammation in an asthma model in mice. J Exp Med 2000; 192: 455-62. (Pubitemid 30629171)
24. Lee DM, Friend DS, Gurish MF, Benoist C, Mathis D, Brenner MB,. Mast cells: a cellular link between autoantibodies and inflammatory arthritis. Science 2002; 297: 1689-92. (Pubitemid 35000781)
25. Nigrovic PA, Lee DM,. Mast cells in inflammatory arthritis. Arthritis Res Ther 2005; 7: 1-11. (Pubitemid 40214522)
26. Secor VH, Secor WE, Gutekunst CA, Brown MA,. Mast cells are essential for early onset and severe disease in a murine model of multiple sclerosis. J Exp Med 2000; 191: 813-22.
27. Robbie-Ryan M, Brown M,. The role of mast cells in allergy and autoimmunity. Curr Opin Immunol 2002; 14: 728-33. (Pubitemid 35292419)
28. Lu LF, Lind EF, Gondek DC, Bennett KA, Gleeson MW, Pino-Lagos K, Scott ZA, Coyle AJ, Reed JL, Van Snick J, Strom TB, Zheng XX, Noelle RJ,. Mast cells are essential intermediaries in regulatory T-cell tolerance. Nature 2006; 442: 997-1002. (Pubitemid 44330250)
29. Gregory GD, Robbie-Ryan M, Secor VH, Sabatino JJ Jr, Brown MA,. Mast cells are required for optimal autoreactive T cell responses in a murine model of multiple sclerosis. Eur J Immunol 2005; 35: 3478-86. (Pubitemid 43025529)
30. Kambayashi T, Baranski JD, Baker RG, Zou T, Allenspach EJ, Shoag JE, Jones PL, Koretzky GA,. Indirect involvement of allergen-captured mast cells in antigen presentation. Blood 2008; 111: 1489-96. (Pubitemid 351213437)
31. Kambayashi T, Allenspach EJ, Chang JT, Zou T, Shoag JE, Reiner SL, Caton AJ, Koretzky GA,. Inducible MHC class II expression by mast cells supports effector and regulatory T cell activation. J Immunol 2009; 182: 4686-95.
32. Gri G, Piconese S, Frossi B, Manfroi V, Merluzzi S, Tripodo C, Viola A, Odom S, Rivera J, Colombo MP, Pucillo CE,. CD4+CD25+ regulatory T cells suppress mast cell degranulation and allergic responses through OX40-OX40L interaction. Immunity 2008; 29: 771-81.
33. Martinez-Moczygemba M, Huston DP,. Biology of common beta receptor-signaling cytokines: IL-3, IL-5, and GM-CSF. J Allergy Clin Immunol 2003; 112: 653-65. Quiz 66.
34. Zou T, Caton AJ, Koretzky GA, Kambayashi T,. Dendritic cells induce regulatory T cell proliferation through antigen-dependent and -independent interactions. J Immunol 2010; 185: 2790-9.
35. Lutz MB,. IL-3 in dendritic cell development and function: a comparison with GM-CSF and IL-4. Immunobiology 2004; 209: 79-87. (Pubitemid 39255694)
36. Swee LK, Bosco N, Malissen B, Ceredig R, Rolink A,. Expansion of peripheral naturally occurring T regulatory cells by FMS-like tyrosine kinase 3 ligand treatment. Blood 2009; 113: 6277-87.
37. Darrasse-Jeze G, Deroubaix S, Mouquet H, Victora GD, Eisenreich T, Yao KH, Masilamani RF, Dustin ML, Rudensky A, Liu K, Nussenzweig MC,. Feedback control of regulatory T cell homeostasis by dendritic cells in vivo. J Exp Med 2009; 206: 1853-62.
38. Gavin MA, Clarke SR, Negrou E, Gallegos A, Rudensky A,. Homeostasis and anergy of CD4(+)CD25(+) suppressor T cells in vivo. Nat Immunol 2002; 3: 33-41. (Pubitemid 34065615)
39. Schorle H, Holtschke T, Hunig T, Schimpl A, Horak I,. Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting. Nature 1991; 352: 621-4. (Pubitemid 21912393)
40. Willerford DM, Chen J, Ferry JA, Davidson L, Ma A, Alt FW,. Interleukin-2 receptor alpha chain regulates the size and content of the peripheral lymphoid compartment. Immunity 1995; 3: 521-30.
41. Suzuki H, Kündig TM, Furlonger C, Wakeham A, Timms E, Matsuyama T, Schmits R, Simard JJ, Ohashi PS, Griesser H, Taniguchi T, Paige CJ, Mak TW,. Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor beta. Science 1995; 268: 1472-6.
42. Malek TR, Yu A, Vincek V, Scibelli P, Kong L,. CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rbeta-deficient mice. Implications for the nonredundant function of IL-2. Immunity 2002; 17: 167-78. (Pubitemid 35245959)
43. Almeida AR, Legrand N, Papiernik M, Freitas AA,. Homeostasis of peripheral CD4+ T cells: IL-2R alpha and IL-2 shape a population of regulatory cells that controls CD4+ T cell numbers. J Immunol 2002; 169: 4850-60. (Pubitemid 35217148)
44. Almeida AR, Zaragoza B, Freitas AA,. Indexation as a novel mechanism of lymphocyte homeostasis: the number of CD4+CD25+ regulatory T cells is indexed to the number of IL-2-producing cells. J Immunol 2006; 177: 192-200. (Pubitemid 43939130)
45. Setoguchi R, Hori S, Takahashi T, Sakaguchi S,. Homeostatic maintenance of natural Foxp3(+) CD25(+) CD4(+) regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization. J Exp Med 2005; 201: 723-35. (Pubitemid 40395118)
46. Jordan MS, Boesteanu A, Reed AJ, Petrone AL, Holenbeck AE, Lerman MA, Naji A, Caton AJ,. Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide. Nat Immunol 2001; 2: 301-6. (Pubitemid 33706340)
47. Walker LS, Chodos A, Eggena M, Dooms H, Abbas AK,. Antigen-dependent proliferation of CD4+ CD25+ regulatory T cells in vivo. J Exp Med 2003; 198: 249-58. (Pubitemid 36992178)
48. Andersson J, Stefanova I, Stephens GL, Shevach EM,. CD4+CD25+ regulatory T cells are activated in vivo by recognition of self. Int Immunol 2007; 19: 557-66. (Pubitemid 46523402)
49. Bhandoola A, Tai X, Eckhaus M, Auchincloss H, Mason K, Rubin SA, Carbone KM, Grossman Z, Rosenberg AS, Singer A,. Peripheral expression of self-MHC-II influences the reactivity and self-tolerance of mature CD4(+) T cells: evidence from a lymphopenic T cell model. Immunity 2002; 17: 425-36. (Pubitemid 35223532)
50. Mach N, Lantz CS, Galli SJ, Reznikoff G, Mihm M, Small C, Granstein R, Beissert S, Sadelain M, Mulligan RC, Dranoff G,. Involvement of interleukin-3 in delayed-type hypersensitivity. Blood 1998; 91: 778-83. (Pubitemid 28078278)
51. Lantz CS, Boesiger J, Song CH, Mach N, Kobayashi T, Mulligan RC, Nawa Y, Dranoff G, Galli SJ,. Role for interleukin-3 in mast-cell and basophil development and in immunity to parasites. Nature 1998; 392: 90-3. (Pubitemid 28150595)
52. Stanley E, Lieschke GJ, Grail D, Metcalf D, Hodgson G, Gall JA, Maher DW, Cebon J, Sinickas V, Dunn AR,. Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology. Proc Natl Acad Sci U S A 1994; 91: 5592-6. (Pubitemid 24174374)
53. Dranoff G, Crawford AD, Sadelain M, Ream B, Rashid A, Bronson RT, Dickersin GR, Bachurski CJ, Mark EL, Whitsett JA, Mulligan RC,. Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis. Science 1994; 264: 713-6. (Pubitemid 24185882)
54. Gillessen S, Mach N, Small C, Mihm M, Dranoff G,. Overlapping roles for granulocyte-macrophage colony-stimulating factor and interleukin-3 in eosinophil homeostasis and contact hypersensitivity. Blood 2001; 97: 922-8. (Pubitemid 32154275)
55. Enzler T, Gillessen S, Dougan M, Allison JP, Neuberg D, Oble DA, Mihm M, Dranoff G,. Functional deficiencies of granulocyte-macrophage colony stimulating factor and interleukin-3 contribute to insulitis and destruction of beta cells. Blood 2007; 110: 954-61. (Pubitemid 47267434)
56. Vasu C, Dogan RN, Holterman MJ, Prabhakar BS,. Selective induction of dendritic cells using granulocyte macrophage-colony stimulating factor, but not FMS-like tyrosine kinase receptor 3-ligand, activates thyroglobulin-specific CD4+/CD25+ T cells and suppresses experimental autoimmune thyroiditis. J Immunol 2003; 170: 5511-22. (Pubitemid 36617839)
57. Gangi E, Vasu C, Cheatem D, Prabhakar BS,. IL-10-producing CD4+CD25+ regulatory T cells play a critical role in granulocyte-macrophage colony-stimulating factor-induced suppression of experimental autoimmune thyroiditis. J Immunol 2005; 174: 7006-13. (Pubitemid 40705665)
58. Sheng JR, Li LC, Ganesh BB, Prabhakar BS, Meriggioli MN,. Regulatory T cells induced by GM-CSF suppress ongoing experimental myasthenia gravis. Clin Immunol 2008; 128: 172-80.
59. Gaudreau S, Guindi C, Menard M, Besin G, Dupuis G, Amrani A,. Granulocyte-macrophage colony-stimulating factor prevents diabetes development in NOD mice by inducing tolerogenic dendritic cells that sustain the suppressive function of CD4+CD25+ regulatory T cells. J Immunol 2007; 179: 3638-47.